MAPK3 and liver cancer: Activated c-MET plays a pivotal role in promoting liver cancer stemness by upregulating downstream signaling molecules, including extracellular signal-regulated kinase 1/2 (ERK1/2), protein kinase B (AKT), and nuclear factor kappa B (NF-κB) [37].